Sonnet BioTherapeutics
Why Robinhood?
You can watch SONN and buy or sell other stocks, ETFs, and their options commission-free!About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
SONN Key Statistics
Stock Snapshot
As of today, Sonnet BioTherapeutics(SONN) shares are valued at $1.26. The company's market cap stands at 6.56M, with a P/E ratio of -1.88.
Sonnet BioTherapeutics(SONN) stock opened on 2026-02-06 at —. The price climbed to — and dipped to —.
The Sonnet BioTherapeutics(SONN)'s current trading volume is 0, compared to an average daily volume of 104.32K.
During the past year, Sonnet BioTherapeutics(SONN) stock moved between $0.62 at its lowest and $2.97 at its peak.
During the past year, Sonnet BioTherapeutics(SONN) stock moved between $0.62 at its lowest and $2.97 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.